Myeloperoxidase and calprotectin; Any role as non-invasive markers for the prediction of ınflammation and fibrosis in non-alcoholic steatohepatitis?
Author(s) -
Ercan Bıçakcı,
Coşkun Özer Demirtaş,
Çiğdem Çelikel,
Goncagül Haklar,
Deniz Duman
Publication year - 2020
Publication title -
the turkish journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 28
eISSN - 2148-5607
pISSN - 1300-4948
DOI - 10.5152/tjg.2020.19403
Subject(s) - medicine , steatohepatitis , calprotectin , myeloperoxidase , gastroenterology , fibrosis , pathology , fatty liver , inflammation , disease , inflammatory bowel disease
Specific serum markers reflecting hepatic inflammation and fibrosis are required to tailor the treatment strategies in non-alcoholic steatohepatitis (NASH). We aimed to investigate the roles of myeloperoxidase (MPO) and calprotectin in predicting the hepatic inflammation status and disease severity in NASH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom